Health and Fitness Health and Fitness
Thu, January 6, 2011
Wed, January 5, 2011
Tue, January 4, 2011
Mon, January 3, 2011
Fri, December 31, 2010
Thu, December 30, 2010
Wed, December 29, 2010
Tue, December 28, 2010
Mon, December 27, 2010
Fri, December 24, 2010
Thu, December 23, 2010
Wed, December 22, 2010
Tue, December 21, 2010
Mon, December 20, 2010
Fri, December 17, 2010
Thu, December 16, 2010
Wed, December 15, 2010
Tue, December 14, 2010
Mon, December 13, 2010
Sun, December 12, 2010
Fri, December 10, 2010
Thu, December 9, 2010
Wed, December 8, 2010
Tue, December 7, 2010

Covidien plc to Report First-Quarter Results on February 1, 2011


//health-fitness.news-articles.net/content/2010/ .. rt-first-quarter-results-on-february-1-2011.html
Published in Health and Fitness on Monday, December 20th 2010 at 4:11 GMT by Market Wire   Print publication without navigation


DUBLIN--([ BUSINESS WIRE ])--Covidien plc (NYSE: COV) will report first-quarter results before trading begins on February 1, 2011. The Company will hold a conference call for investors at 8:30 a.m. ET. The call can be accessed in the following ways:

  • At Covidiena™s website: [ http://investor.covidien.com ]
  • By telephone: For both alisten-onlya participants and those participants who wish to take part in the question-and-answer portion of the call, the telephone dial-in number in the U.S. is 866-700-7101. For participants outside the U.S., the dial-in number is 617-213-8837. The access code for all callers is 21441069.
  • Through an audio replay: A replay of the conference call will be available beginning at 11:30 a.m. on February 1, 2011, and ending at 5:00 p.m. on February 8, 2011. The dial-in number for U.S. participants is 888-286-8010. For participants outside the U.S., the replay dial-in number is 617-801-6888. The replay access code for all callers is 93591283.

ABOUT COVIDIEN

Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien manufactures, distributes and services a diverse range of industry-leading product lines in three segments: Medical Devices, Pharmaceuticals and Medical Supplies. With 2010 revenue of $10.4 billion, Covidien has approximately 42,000 employees worldwide in more than 60 countries, and its products are sold in over 140 countries. Please visit [ www.covidien.com ] to learn more about our business.


Publication Contributing Sources